Cargando…
BLX‐1002 restores glucose sensitivity and enhances insulin secretion stimulated by GLP‐1 and sulfonylurea in type 2 diabetic pancreatic islets
BLX‐1002 is a novel thiazolidinedione with no peroxisome proliferator‐activated receptor (PPAR) activity that has been shown to improve glycemia in type 2 diabetes without weight gain. We previously found that BLX‐1002 selectively augments glucose‐sensitive (but not basal) insulin secretion in norma...
Autores principales: | Zhang, Qimin, Zhang, Fan, Sjöholm, Åke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098742/ https://www.ncbi.nlm.nih.gov/pubmed/24872354 http://dx.doi.org/10.14814/phy2.12014 |
Ejemplares similares
-
Effectiveness of Nateglinide on In Vitro Insulin Secretion from Rat Pancreatic Islets
Desensitized to Sulfonylureas
por: Hu, Shiling, et al.
Publicado: (2001) -
Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets
por: Cheng, Yi, et al.
Publicado: (2023) -
Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
por: Jing, Muhan, et al.
Publicado: (2021) -
Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells
por: Kappe, Camilla, et al.
Publicado: (2014) -
Mechanistic Investigation of GHS-R Mediated Glucose-Stimulated Insulin Secretion in Pancreatic Islets
por: Pradhan, Geetali, et al.
Publicado: (2022)